Ability Biotherapeutics Alternatives & Competitors
12 companies similar to Ability Biotherapeutics — Developing innovative targeted immuno therapeutics to addressing unmet medical n...
Georgiamune Inc.
Georgiamune is reprogramming immune signaling pathways to redirect the immune system to fi...
Gaithersburg, United Stat...
HAYA Therapeutics
Programmable Therapeutics for Causal Biology - Science Guides Us. The Genome Powers Us. P...
Switzerland
Enlaza Therapeutics
Pioneering Covalent Biologics
San Diego, United States
Replicate Bioscience, Inc.
The Power of RNA Amplified
San Diego, United States
Track all Ability Biotherapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Repertoire Immune Medicines
Repertoire is a biotechnology company creating a new category of immune medicines for canc...
Cambridge, United States
Granza Bio
Reprogramming Immunity for Target-Specific Medicines
Treeline
Making medicines at the highest level
Watertown, United States
Adendra Therapeutics
Translating dendritic cell biology into new therapies for cancer and autoimmunity.
London, United Kingdom
Orbital Therapeutics
Expanding RNA medicines to more tissues, more diseases, and more patients.
Cambridge, United States
Io Therapeutics
Io therapeutics focuses on developing drugs that target nuclear receptors in order to trea...
HotSpot Therapeutics, Inc.
Discovering new allosteric therapies with the ability to treat disease in new ways
Boston, United States
Kernal Biologics
KernalBio creates mRNA therapies that instruct specific cells on how to make their own med...
Cambridge, United States
About Ability Biotherapeutics
Developing innovative targeted immuno therapeutics to addressing unmet medical needs for cancer and autoimmune diseases
Development of precision therapies, Immune cell modulating biotherapeutics, Antibody discovery and engineering, Product candidates pipeline
Biopharmaceutical companies, Research institutions, Healthcare providers, Patients with inflammatory diseases, Cancer patients
Targeted Immunotherapy, Cancer Treatment, Autoimmune Diseases, Biotherapeutics, Antibody Development, AI-Driven Drug Discovery, AbiLeap Discovery Engine, Multispecific Antibodies, Human IgG Antibodies, Immune Modulating Therapies, Antigen-Antibody Interactions, Logic-Gated Therapeutics, Cellular Microenvironment Response, AI/ML In Biotech, Biotech Innovation
B2B, Platform
Licensing, Performance Based, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Ability Biotherapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Ability Biotherapeutics on 15 Jun 2026. The 12 companies listed here were last checked between 28 Jan 2026 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.